Alexandra Borodovsky

Alexandra Borodovsky is a Director at Nurix Therapeutics with extensive expertise in oncology drug discovery, including small molecule development and immuno-oncology. They hold a Ph.D. in Cellular and Molecular Medicine from Johns Hopkins School of Medicine, where they developed a novel brain cancer model that was licensed to a pharmaceutical company. Previously, Alexandra contributed to significant research projects as a Senior Scientist and Associate Principal Scientist at AstraZeneca. Their leadership experience includes managing a science-focused summer camp and serving as the President of the Phi Sigma Biological Honors Society.